Cargando…
Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization
INTRODUCTION: Resurgence of pertussis, caused by Bordetella pertussis, necessitates novel vaccines and vaccination strategies to combat this disease. Alum-adjuvanted acellular pertussis vaccines (aPV) delivered intramuscularly reduce bacterial numbers in the lungs of immunized animals and humans, bu...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232778/ https://www.ncbi.nlm.nih.gov/pubmed/37275891 http://dx.doi.org/10.3389/fimmu.2023.1181876 |
_version_ | 1785052064821280768 |
---|---|
author | Yount, Kacy S. Hall, Jesse M. Caution, Kyle Shamseldin, Mohamed M. Guo, Myra Marion, Keirsten Fullen, Audra R. Huang, Yimin Maynard, Jennifer A. Quataert, Sally A. Deora, Rajendar Dubey, Purnima |
author_facet | Yount, Kacy S. Hall, Jesse M. Caution, Kyle Shamseldin, Mohamed M. Guo, Myra Marion, Keirsten Fullen, Audra R. Huang, Yimin Maynard, Jennifer A. Quataert, Sally A. Deora, Rajendar Dubey, Purnima |
author_sort | Yount, Kacy S. |
collection | PubMed |
description | INTRODUCTION: Resurgence of pertussis, caused by Bordetella pertussis, necessitates novel vaccines and vaccination strategies to combat this disease. Alum-adjuvanted acellular pertussis vaccines (aPV) delivered intramuscularly reduce bacterial numbers in the lungs of immunized animals and humans, but do not reduce nasal colonization. Thus, aPV-immunized individuals are sources of community transmission. We showed previously that modification of a commercial aPV (Boostrix) by addition of the Th1/17 polarizing adjuvant Bordetella Colonization Factor A (BcfA) attenuated Th2 responses elicited by alum and accelerated clearance of B. pertussis from mouse lungs. Here we tested whether a heterologous immunization strategy with systemic priming and mucosal booster (prime-pull) would reduce nasal colonization. METHODS: Adult male and female mice were immunized intramuscularly (i.m.) with aPV or aPV/BcfA and boosted either i.m. or intranasally (i.n.) with the same formulation. Tissue-resident memory (TRM) responses in the respiratory tract were quantified by flow cytometry, and mucosal and systemic antibodies were quantified by ELISA. Immunized and naïve mice were challenged i.n. with Bordetella pertussis and bacterial load in the nose and lungs enumerated at days 1-14 post-challenge. RESULTS: We show that prime-pull immunization with Boostrix plus BcfA (aPV/BcfA) generated IFNγ+ and IL-17+ CD4+ lung resident memory T cells (TRM), and CD4+IL-17+ TRM in the nose. In contrast, aPV alone delivered by the same route generated IL-5+ CD4+ resident memory T cells in the lungs and nose. Importantly, nasal colonization was only reduced in mice immunized with aPV/BcfA by the prime-pull regimen. CONCLUSIONS: These results suggest that TH17 polarized TRM generated by aPV/BcfA may reduce nasal colonization thereby preventing pertussis transmission and subsequent resurgence. |
format | Online Article Text |
id | pubmed-10232778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102327782023-06-02 Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization Yount, Kacy S. Hall, Jesse M. Caution, Kyle Shamseldin, Mohamed M. Guo, Myra Marion, Keirsten Fullen, Audra R. Huang, Yimin Maynard, Jennifer A. Quataert, Sally A. Deora, Rajendar Dubey, Purnima Front Immunol Immunology INTRODUCTION: Resurgence of pertussis, caused by Bordetella pertussis, necessitates novel vaccines and vaccination strategies to combat this disease. Alum-adjuvanted acellular pertussis vaccines (aPV) delivered intramuscularly reduce bacterial numbers in the lungs of immunized animals and humans, but do not reduce nasal colonization. Thus, aPV-immunized individuals are sources of community transmission. We showed previously that modification of a commercial aPV (Boostrix) by addition of the Th1/17 polarizing adjuvant Bordetella Colonization Factor A (BcfA) attenuated Th2 responses elicited by alum and accelerated clearance of B. pertussis from mouse lungs. Here we tested whether a heterologous immunization strategy with systemic priming and mucosal booster (prime-pull) would reduce nasal colonization. METHODS: Adult male and female mice were immunized intramuscularly (i.m.) with aPV or aPV/BcfA and boosted either i.m. or intranasally (i.n.) with the same formulation. Tissue-resident memory (TRM) responses in the respiratory tract were quantified by flow cytometry, and mucosal and systemic antibodies were quantified by ELISA. Immunized and naïve mice were challenged i.n. with Bordetella pertussis and bacterial load in the nose and lungs enumerated at days 1-14 post-challenge. RESULTS: We show that prime-pull immunization with Boostrix plus BcfA (aPV/BcfA) generated IFNγ+ and IL-17+ CD4+ lung resident memory T cells (TRM), and CD4+IL-17+ TRM in the nose. In contrast, aPV alone delivered by the same route generated IL-5+ CD4+ resident memory T cells in the lungs and nose. Importantly, nasal colonization was only reduced in mice immunized with aPV/BcfA by the prime-pull regimen. CONCLUSIONS: These results suggest that TH17 polarized TRM generated by aPV/BcfA may reduce nasal colonization thereby preventing pertussis transmission and subsequent resurgence. Frontiers Media S.A. 2023-05-18 /pmc/articles/PMC10232778/ /pubmed/37275891 http://dx.doi.org/10.3389/fimmu.2023.1181876 Text en Copyright © 2023 Yount, Hall, Caution, Shamseldin, Guo, Marion, Fullen, Huang, Maynard, Quataert, Deora and Dubey https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Yount, Kacy S. Hall, Jesse M. Caution, Kyle Shamseldin, Mohamed M. Guo, Myra Marion, Keirsten Fullen, Audra R. Huang, Yimin Maynard, Jennifer A. Quataert, Sally A. Deora, Rajendar Dubey, Purnima Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization |
title | Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization |
title_full | Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization |
title_fullStr | Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization |
title_full_unstemmed | Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization |
title_short | Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization |
title_sort | systemic priming and intranasal booster with a bcfa-adjuvanted acellular pertussis vaccine generates cd4+ il-17+ nasal tissue resident t cells and reduces b. pertussis nasal colonization |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232778/ https://www.ncbi.nlm.nih.gov/pubmed/37275891 http://dx.doi.org/10.3389/fimmu.2023.1181876 |
work_keys_str_mv | AT yountkacys systemicprimingandintranasalboosterwithabcfaadjuvantedacellularpertussisvaccinegeneratescd4il17nasaltissueresidenttcellsandreducesbpertussisnasalcolonization AT halljessem systemicprimingandintranasalboosterwithabcfaadjuvantedacellularpertussisvaccinegeneratescd4il17nasaltissueresidenttcellsandreducesbpertussisnasalcolonization AT cautionkyle systemicprimingandintranasalboosterwithabcfaadjuvantedacellularpertussisvaccinegeneratescd4il17nasaltissueresidenttcellsandreducesbpertussisnasalcolonization AT shamseldinmohamedm systemicprimingandintranasalboosterwithabcfaadjuvantedacellularpertussisvaccinegeneratescd4il17nasaltissueresidenttcellsandreducesbpertussisnasalcolonization AT guomyra systemicprimingandintranasalboosterwithabcfaadjuvantedacellularpertussisvaccinegeneratescd4il17nasaltissueresidenttcellsandreducesbpertussisnasalcolonization AT marionkeirsten systemicprimingandintranasalboosterwithabcfaadjuvantedacellularpertussisvaccinegeneratescd4il17nasaltissueresidenttcellsandreducesbpertussisnasalcolonization AT fullenaudrar systemicprimingandintranasalboosterwithabcfaadjuvantedacellularpertussisvaccinegeneratescd4il17nasaltissueresidenttcellsandreducesbpertussisnasalcolonization AT huangyimin systemicprimingandintranasalboosterwithabcfaadjuvantedacellularpertussisvaccinegeneratescd4il17nasaltissueresidenttcellsandreducesbpertussisnasalcolonization AT maynardjennifera systemicprimingandintranasalboosterwithabcfaadjuvantedacellularpertussisvaccinegeneratescd4il17nasaltissueresidenttcellsandreducesbpertussisnasalcolonization AT quataertsallya systemicprimingandintranasalboosterwithabcfaadjuvantedacellularpertussisvaccinegeneratescd4il17nasaltissueresidenttcellsandreducesbpertussisnasalcolonization AT deorarajendar systemicprimingandintranasalboosterwithabcfaadjuvantedacellularpertussisvaccinegeneratescd4il17nasaltissueresidenttcellsandreducesbpertussisnasalcolonization AT dubeypurnima systemicprimingandintranasalboosterwithabcfaadjuvantedacellularpertussisvaccinegeneratescd4il17nasaltissueresidenttcellsandreducesbpertussisnasalcolonization |